CORC

在结果中检索

CORC

浏览/检索结果: 共48条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：34/0  |  提交时间：2019/12/05
Engineered Bacterial Bioreactor for Tumor Therapy via Fenton-Like Reaction with Localized H2O2 Generation 期刊论文
ADVANCED MATERIALS, 2019, 卷号: 31, 期号: 16
作者:  Fan, Jin-Xuan;  Peng, Meng-Yun;  Wang, He;  Zheng, Hao-Ran;  Liu, Zong-Lin
收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05
Trends in Hospitalization and In-Hospital Mortality From VTE, 2007 to 2016, in Chin 期刊论文
CHEST, 2019, 卷号: 155, 期号: 2
作者:  Zhang, Zhu;  Lei, Jieping;  Shao, Xiang;  Dong, Fen;  Wang, Jing
收藏  |  浏览/下载：63/0  |  提交时间：2019/12/05
The Development of Polymer Physics and Characterization in Mainland China since Reform and Opening-up 期刊论文
ACTA POLYMERICA SINICA, 2019, 卷号: 50, 期号: 10
作者:  An, Li-jia;  Chen, Er-qiang;  Cui, Shu-xun;  Dong, Xia;  Fu, Qiang
收藏  |  浏览/下载：35/0  |  提交时间：2019/12/05
Incidence of portal vein thrombosis after splenectomy and its influence on transjugular intrahepatic portosystemic shunt stent patency 期刊论文
WORLD JOURNAL OF CLINICAL CASES, 2019, 卷号: 7, 期号: 17
作者:  Dong, Fang;  Luo, Shi-Hua;  Zheng, Li-Juan;  Chu, Jian-Guo;  Huang, He
收藏  |  浏览/下载：16/0  |  提交时间：2019/12/05
GRID: a student project to monitor the transient gamma-ray sky in the multi-messenger astronomy era 期刊论文
EXPERIMENTAL ASTRONOMY, 2019, 卷号: 48, 期号: 1
作者:  Wen, Jiaxing;  Long, Xiangyun;  Zheng, Xutao;  An, Yu;  Cai, Zhengyang
收藏  |  浏览/下载：145/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：36/0  |  提交时间：2019/12/05
THE EFFICACY AND SAFETY OF RAVIDASVIR COMBINED WITH DANOPREVIR IN THE 12-WEEK ORAL REGIMEN FOR TREATMENT-NAIVE HCV GENOTYPE 1 ADULT PATIENTS WITHOUT CIRRHOSIS IN CHINA: PHASE II/III CLINICAL TRIAL 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Zheng, Sujun;  Guan, Yujuan;  Sheng, Jifang
收藏  |  浏览/下载：32/0  |  提交时间：2019/12/05
Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats 期刊论文
ACTA PHARMACOLOGICA SINICA, 2019, 卷号: 40, 期号: 3
作者:  He, Xiang-hu;  Jordan, Chloe J.;  Vemuri, Kiran;  Bi, Guo-hua;  Zhan, Jia
收藏  |  浏览/下载：16/0  |  提交时间：2019/12/05
All-oral, 12-week ravidasvir plus ritonavir-boosted danoprevir and ribavirin delivers 100% svr12 in treatment-naive non-cirrhotic hcv genotype 1 patients with resistance-associated substitutions of a phase 2/3 clinical trial in china 会议论文
作者:  Wei, Lai;  Xu, Xiaoyuan;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Ji-Fang
收藏  |  浏览/下载：29/0  |  提交时间：2019/12/05

©版权所有 ©2017 CSpace - Powered by CSpace